Tourmaline Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	377	532	43	632
Market Cap Growth	643.53%	1151.06%	-93.27%	-
Enterprise Value	88	330	35	388
PE Ratio	-	-12.64	-2.16	-13.22
PB Ratio	1.08	2.60	-2.16	2.60
P/FCF Ratio	-22.73	-18.92	-6.52	-14.90
P/OCF Ratio	-22.50	-18.96	-6.59	-15.81
EV/EBITDA Ratio	-8.82	-7.86	-1.76	-8.23
EV/EBIT Ratio	-8.94	-7.83	-1.76	-8.12
EV/FCF Ratio	-11.39	-11.72	-5.30	-9.15
Debt / Equity Ratio	0.00	0.00	-0.03	-
Debt / EBITDA Ratio	-0.01	-0.01	-0.03	-
Debt / FCF Ratio	-0.01	-0.01	-0.08	-
Quick Ratio	60.76	40.62	6.22	30.55
Current Ratio	62.17	41.76	6.10	30.86
Return on Equity (ROE)	-15.50%	-25.60%	-12.90%	-26.60%
Return on Assets (ROA)	-15.00%	-24.30%	-11.70%	-20.60%
Return on Capital (ROIC)	-10.96%	-22.10%	102.46%	-19.57%
Earnings Yield	-8.64%	-7.91%	-46.29%	-7.56%
FCF Yield	-6.78%	-5.28%	-15.33%	-6.71%
Dividend Yield	6.60%	5.80%	0.00%	0.00%
Payout Ratio	-37.10%	-17.00%	0.00%	0.00%
Buyback Yield / Dilution	-2558.06%	-441.28%	69.89%	-335.69%
Total Shareholder Return	-2558.06%	-435.48%	69.89%	-335.69%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).